145 results on '"Cotten, Steven W."'
Search Results
2. Development and validation of an LC-MSMS method to quantify creatinine from dried blood spots
3. List of contributors
4. Kratom, a novel herbal opioid in a patient with benzodiazepine use disorder
5. List of contributors
6. Evaluation of exocrine pancreatic function
7. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study
8. Method performance and clinical workflow outcomes associated with meconium and umbilical cord toxicology testing
9. List of Contributors
10. Advances in Meconium Analysis for Assessment of Neonatal Drug Exposure
11. A Review of Current Practices and Future Trends in Body Fluid Testing
12. Development of 8‐Hour Urine Collections and an Augmented Renal Clearance Dosing Program at an Academic Medical Center
13. Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?
14. An Introduction to Drug Testing: The Expanding Role of Mass Spectrometry
15. Comparing Commercial, Vendor-Specific vs Open-Source Business Intelligence Dashboard Solutions
16. Concordance of Chronic Kidney Disease Stage and Metformin Management Using CKD-EPI 2021 Race-Free Equation vs CKD-EPI 2009 Equation to Estimate Glomerular Filtration Rate
17. A Paradigm Shift:Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods
18. Drug Testing in the Neonate
19. Corrigendum to: Comparison of Five Common Analyzers in the Measurement of Chemistry Analytes in an Authentic Cohort of Body Fluid Specimens
20. A Paradigm Shift: Engagement of Clinical Chemistry and Laboratory Medicine Trainees by Innovative Teaching Methods
21. Comparison of Five Common Analyzers in the Measurement of Chemistry Analytes in an Authentic Cohort of Body Fluid Specimens
22. The Lines That Held Us: Assessing Racial and Socioeconomic Disparities in SARS-CoV-2 Testing
23. Chapter 19.2 - Kratom, a novel herbal opioid in a patient with benzodiazepine use disorder
24. Chapter 33 - Evaluation of exocrine pancreatic function
25. An Introduction to Drug Testing: The Expanding Role of Mass Spectrometry
26. The 2018 AACC/SYCL PhD Clinical Chemist Compensation Survey
27. Letter to the Editor.
28. mRNA-Display-Based Selections for Proteins with Desired Functions: A Protease-Substrate Case Study
29. Method Performance of Bicarbonate and Electrolytes by Use of Duodenal Fluid for Assessment of Exocrine Pancreatic Function
30. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures
31. Discovery of small molecule inhibitors for the C. elegans caspase CED-3 by high-throughput screening
32. Antinuclear Antibody Screening: A Delicate Balance for Clinical Laboratories
33. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures
34. Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease
35. Method-dependent Discrepancies in Fetal Hemoglobin Quantification in Patients With Hemoglobin S
36. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures
37. Facing Challenges in Neonatal Drug Testing: HOW LABORATORY STEWARDSHIP ENHANCES CARE FOR A VULNERABLE POPULATION.
38. Direct Bilirubin Higher Than Total Bilirubin?
39. The new collaborative path in medical device development: The medical device innovation consortium
40. Cyclodextrin Removal of Lipemic Interference: An Attractive Alternative to Ultracentrifugation for Satellite Laboratories
41. New FDA Partnerships: Creating a Space for Innovative Device Development
42. Evaluation of digital images for identification and characterization of monoclonal immunoglobulins by immunofixation
43. Modulation of nucleobindin-1 and nucleobindin-2 by caspases
44. Response to Mays and McCarthy
45. Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay
46. Regulation of the calpain and ubiquitin proteasome system in a canine model of muscular dystrophy with myostatin inhibition
47. Multiple Positive Sweat Chloride Tests in an Infant Asymptomatic for Cystic Fibrosis
48. Albert Szent-Györgyi, MD, PhD
49. Kids in America: Newborn Screening for Cystic Fibrosis
50. Selection of proteins with desired properties from natural proteome libraries using mRNA display
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.